News
We have developed a non-radioactive flow-cytometry assay to monitor and quantify the target-cell killing activities mediated by cytotoxic T lymphocytes (CTLs). This flow-cytometry CTL (FCC ...
A low-profile child of the '60s, flow cytometry didn't capture the imagination of most ... Bio-Rad’s KINESIS reagent kits for flow cytometry assays A flow cytometer shines one or more lasers on a ...
Most flow cytometry assays are lab-developed tests (LDTs ... The standard CAR approach uses T cells, which are primed to fight infections. With the right gene editing, they can be engineered ...
Crown BioScience experts explore organoid models and high-content imaging to evaluate T-cell-targeted therapies and ...
“For the most part, flow cytometry is used when you have a good affinity assay—an antibody or oligomer probe that can specifically label your cell type,” ...
The Cytometry and Cell Sorting Facility at Baylor College of Medicine provides training, instrumentation, technical expertise, and software for flow cytometric analysis and cell sorting. This site ...
The Flow Cytometry and Cell Separation Facility provides advanced cell sorting and cell analysis techniques including immunofluorescence detection of 18 colors, cell-cycle distribution, apoptosis ...
Hosted on MSN17d
A new approach to cancer treatment: Tiny vesicles help the immune system fight tumorsflow cytometry, and molecular assays to track immune responses and tumor growth. By observing how immune cells reacted to AP-EVs, they confirmed that these vesicles could selectively stimulate T cells ...
Its intuitive touchscreen interface, easy-to-use software, and optimized “Mix-and-Read” assays combine to streamline and simplify flow cytometry analyses. The Muse Micro cell analyzer is built ...
It can precisely select single cells on a chip, carry out several single-cell assays, and export target ... of their membranes are organized by flow cytometry. What is the maximum number of ...
The following is a summary of “Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab,” published in the April 2025 issue of Journal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results